Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)

NCT02141685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-07-13

No results posted yet for this study

Summary

The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva parameters with array - Comparative Genomic Hybridization (aCGH) results and ongoing pregnancy rates.

Conditions

Sponsors & Collaborators

  • Progyny, Inc.

    lead INDUSTRY

Principal Investigators

  • Shehua Shen, MD, ELD · Progyny, Inc.

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02141685 on ClinicalTrials.gov